Showing results for 
Search instead for 
Did you mean: 
Level 9
Report Inappropriate Content
Message 11 of 13

Re: Bad performance with move 2.6

It's not the same license file. You can download the license file where you download the Multi-Platform software. Then just install the zipped license file as an Extension in ePO.

Re: Bad performance with move 2.6

We are looking at implementing Move 2.6 with Patch 2, we have already purchased the product and are currently running over 810+ VM's combined in our production and test environments. (Running ESXi 5.0 Update 1 on 72 hosts)

We have mixed hardware both Dell 610 Blades/R900's and Cisco UCS B230's.

Can you tell me what hardware your running your environment's on?

We are running the full McAfee thick client on nearly all of the VM's presently, mixed between Windows 2000 - 2008 R2 64 with either 8.7 Patch 5 or 8.8 Patch 2.

We have over 130 Citrix PVS Servers in our environment which were struggling for performance with the full virus scan client product.

We are concerned with the performance issues people have been mentioning.

I would appreciate any additional information you can give me on the Move product overall, pro's vs con's and other 'realworld' experiences you have had implementing and maintaining it.

Thank you

Message was edited by: thannam on 5/29/13 12:48:42 PM CDT

Message was edited by: thannam on 5/29/13 1:12:53 PM CDT
Level 10
Report Inappropriate Content
Message 13 of 13

Re: Bad performance with move 2.6

I've got MOVE-AV Agentless 2.6 running on our VMWare View infrastructure. We have ~480 virtual desktops (around 220 concurrent connections) over 4 CISCO UCS B250 M2 blades.

We are not having any performance issues at all.

ePO Support Center Plug-in
Check out the new ePO Support Center. Simply access the ePO Software Manager and follow the instructions in the Product Guide for the most commonly used utilities, top known issues announcements, search the knowledgebase for product documentation, and server status and statistics – all from within ePO.